Quidel (QDEL) Hits New 52-Week High and Low at $55.98

Shares of Quidel Co. (NASDAQ:QDEL) reached a new 52-week high and low on Friday . The stock traded as low as $55.98 and last traded at $55.90, with a volume of 124559 shares trading hands. The stock had previously closed at $55.53.

Several research firms have weighed in on QDEL. BidaskClub upgraded shares of Quidel from a “hold” rating to a “buy” rating in a research note on Saturday, March 10th. Zacks Investment Research upgraded shares of Quidel from a “sell” rating to a “hold” rating in a research note on Wednesday, March 28th. ValuEngine upgraded shares of Quidel from a “sell” rating to a “hold” rating in a research note on Tuesday, April 3rd. Piper Jaffray reiterated a “buy” rating and set a $63.00 target price on shares of Quidel in a research note on Wednesday, April 4th. Finally, Raymond James Financial upgraded shares of Quidel from an “outperform” rating to a “strong-buy” rating and lowered their target price for the company from $55.00 to $47.00 in a research note on Thursday, March 8th. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and three have assigned a strong buy rating to the stock. Quidel presently has an average rating of “Buy” and a consensus price target of $57.29.

The firm has a market cap of $1,901.20, a PE ratio of -792.86, a price-to-earnings-growth ratio of 0.91 and a beta of 0.89. The company has a debt-to-equity ratio of 1.66, a quick ratio of 2.06 and a current ratio of 2.58.



Quidel (NASDAQ:QDEL) last announced its quarterly earnings results on Wednesday, February 21st. The company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.70. Quidel had a negative net margin of 2.94% and a negative return on equity of 3.02%. The company had revenue of $114.90 million during the quarter, compared to the consensus estimate of $115.06 million. During the same quarter in the previous year, the company posted $0.17 earnings per share. The company’s revenue for the quarter was up 117.6% compared to the same quarter last year. research analysts anticipate that Quidel Co. will post 2.4 earnings per share for the current fiscal year.

In related news, Director Jack W. Schuler sold 12,000 shares of the company’s stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $48.50, for a total value of $582,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Douglas C. Bryant sold 36,000 shares of the company’s stock in a transaction dated Thursday, March 29th. The stock was sold at an average price of $51.63, for a total transaction of $1,858,680.00. Following the completion of the sale, the chief executive officer now directly owns 306,313 shares of the company’s stock, valued at approximately $15,814,940.19. The disclosure for this sale can be found here. In the last three months, insiders have sold 120,000 shares of company stock valued at $5,751,720. Corporate insiders own 22.00% of the company’s stock.

A number of hedge funds have recently bought and sold shares of QDEL. Russell Investments Group Ltd. lifted its holdings in Quidel by 57.2% in the third quarter. Russell Investments Group Ltd. now owns 12,108 shares of the company’s stock worth $531,000 after purchasing an additional 4,408 shares during the period. Ameriprise Financial Inc. acquired a new stake in Quidel in the third quarter worth about $2,206,000. American International Group Inc. lifted its holdings in Quidel by 8.1% in the third quarter. American International Group Inc. now owns 18,605 shares of the company’s stock worth $816,000 after purchasing an additional 1,390 shares during the period. Great West Life Assurance Co. Can lifted its holdings in Quidel by 162.7% in the third quarter. Great West Life Assurance Co. Can now owns 4,642 shares of the company’s stock worth $204,000 after purchasing an additional 2,875 shares during the period. Finally, Legal & General Group Plc lifted its holdings in Quidel by 55.4% in the third quarter. Legal & General Group Plc now owns 11,204 shares of the company’s stock worth $492,000 after purchasing an additional 3,995 shares during the period. 93.27% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Quidel (QDEL) Hits New 52-Week High and Low at $55.98” was reported by Dakota Financial News and is the property of of Dakota Financial News. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at https://dakotafinancialnews.com/2018/04/13/quidel-qdel-hits-new-52-week-high-and-low-at-55-98.html.

Quidel Company Profile

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.

Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply